ACLF in Patients With HBV-related Compensated Liver Disease ACLF in Patients With HBV-related Compensated Liver Disease
This study tested the performance of the MELD model to characterize ACLF development within 28 days in HBV-related hospitalized patients without previous decompensation.Journal of Viral Hepatitis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
More News: Gastroenterology | Health | Hepatitis | Liver | Liver Disease | Study | Urology & Nephrology